Axogen Announces Plan for CEO Leadership Transition

UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that President and Chief Executive Officer (CEO) Karen Zaderej plans to retire from the company by January 2025. The company’s Board of Directors will retain an executive recruitment firm to manage a search for her successor. Under her leadership, the company has built awareness of the patient quality of life impact related to nerve damage and has created the market for nerve repair.

Founded in 2002 by John Engels and Jamie Grooms, Axogen was a pioneer in the startup space and helped launch the entrepreneurial hub that Gainesville is today. Through innovative nerve repair technology and investment in other health and biotech startups, Axogen’s partnership with the University of Florida has improved the lives of patients and fostered a spirit of innovation.

Read more about Axogen Announces Plan for CEO Leadership Transition.